Table 1.
Major components of extracellular vesicles and their functions described.
| Origin | Molecule | Function | Reference |
|---|---|---|---|
| Tumor | MHC I and II | Antigen presentation | [18] |
| miRNA and mRNA | Oncogenic activity, drug resistance, and metastasis angiogenesis | [19–22] | |
| CXCR4 and MMP-9 | Invasion and migration | [23] | |
| TrkB, EGFR, and TES complex | Angiogenesis | [24] | |
| Rab22A, Pabp1, and PSA | Metastasis | [25–27] | |
| CD40, CD80, CD86, and CD54 | Immunity | [28] | |
| GTPase and Rab27a | Upregulated immune system and inhibited tumor growth | [29] | |
|
| |||
| Bacteria | OmpQ and pertactin | Immunogenic | [30] |
| Gene transfer | Communication | [31] | |
| Gentamycin | Cell death | [32] | |
| RNAs | Communication | [33, 34] | |
|
| |||
| Protozoa | tGPI-mucin | Activation | [35] |
| Tc85 | Invasion/adhesion | [36] | |
| gp63 and LPG | Virulence factor | [37–39] | |
| TS | Virulence factor | [40, 41] | |
|
| |||
| Fungi | α-gal | Immunogenic | [42] |
| GXM and GlcCer | Virulence factor | [43–45] | |
|
| |||
| Eukaryotic mammalian cells | MHC I and II | Antigen presentation | [2] |
| FasL | Immune suppression | [13] | |